Guerrero Dubert, Baker Thomas, Corn Megan, Keup Sean, Nickell Austin, Cao Li
University of North Dakota School of Medicine and Health Sciences, 1301 North Columbia Road, Grand Forks, ND 58202-9037, United States.
Sanford Health, Fargo, ND, United States.
Vaccine X. 2024 Mar 13;18:100473. doi: 10.1016/j.jvacx.2024.100473. eCollection 2024 Jun.
Vaccination is considered the most promising approach for addressing the COVID-19 pandemic. However, even vaccinated people remain at risk. In this study, we examined the association between levels of vaccination and clinical outcomes in hospitalized patients. We conducted a retrospective review of adults hospitalized with COVID-19 infection. Of 484 patients, fully vaccinated (OR = 0.49, p = 0.001) and updated patients (OR = 0.46, p = 0.004) had significantly lower probability of critical severity compared to unvaccinated. Vaccination status is significantly related with 30-day mortality (p = 0.005) but not significantly associated with need for respiratory support or ICU stay. Mean length of stay (LOS) of 6.6 days among boosted patients is significantly lower than patients with no vaccination status (10.7 d, p < 0.001). Our study findings provide real-world evidence of the benefit of booster vaccinations against critical infection and death as well as shortcomings in ICU stay, length of stay or need for ventilatory support.
接种疫苗被认为是应对新冠疫情最具前景的方法。然而,即使接种了疫苗的人仍有风险。在本研究中,我们调查了住院患者的疫苗接种水平与临床结果之间的关联。我们对因新冠病毒感染住院的成年人进行了回顾性研究。在484名患者中,与未接种疫苗的患者相比,完全接种疫苗的患者(比值比=0.49,p=0.001)和接种加强针的患者(比值比=0.46,p=0.004)出现重症的概率显著更低。疫苗接种状态与30天死亡率显著相关(p=0.005),但与呼吸支持需求或入住重症监护病房无关。接种加强针的患者平均住院时间为6.6天,显著低于未接种疫苗的患者(10.7天,p<0.001)。我们的研究结果提供了真实世界的证据,证明接种加强针可预防重症感染和死亡,同时也揭示了在入住重症监护病房、住院时间或呼吸支持需求方面存在的不足。